Notable
PRT12396 · Select Myeloproliferative Neoplasms
Sponsor changed: Prelude Therapeutics to Prelude Therapeutics Incorporated
And 1 more change in the last 30 days
Prelude Therapeutics IncorporatedPhase 1 NCT07469891 Registry history of NCT07469891 on ClinicalTrials.gov (opens the registry)
Updated